Specific Projects. In addition to the general consulting services described in Section 1 above, Client agrees to complete the following projects (together the “Specific Projects”): Project #1 - Complete SOLAR and implement actions related to the FDA meeting (none envisaged for ATLL as of this point) Project #2 - Select a lead candidate for the miR 29 program in IPF, applying the Client’s typical rigorous data and selection standards (this has been done except we want to be sure we also have studies planned to elaborate the PK/PD profile more fully and to assess a reduction in lung fibrosis in a model (or models) of established fibrotic disease) Project #3 – Complete a comprehensive BD diligence room for all R&D assets for potential partnering
Appears in 3 contracts
Sources: Separation Agreement (Miragen Therapeutics, Inc.), Consulting Agreement (Miragen Therapeutics, Inc.), Consulting Agreement (Miragen Therapeutics, Inc.)